Page 12 - Global Restructuring News Today

Andrew Bailey under pressure over link to RBS scandal Andrew Bailey has been Governor of the Bank of England for a year. He was formerly the head of the Financial Conduct Authority. (Getty Images) Bank of England Governor Andrew Bailey is under fire after it emerged that he played a role in designing a scheme that left thousands of small businesses in ruin after the financial crisis. Bailey was one of those who helped the Treasury design its Asset Protection Agency, which press...

27 Greenberg Traurig Attorneys Recognized in 2021 Edition of Georgia Super Lawyers Share Article Global law firm Greenberg Traurig, LLP Co-President Ernest LaMont Greer and Lori G. Cohen, vice chair of the firm, co-chair of the Global Litigation Practice, and chair of the Trial Practice Group, are included in the “Top 100: 2021 Georgia Super Lawyers List.” Additionally, Cohen is listed on the “Top 10” list as well as the “Top 50: Women” list. ATLANTA ...

Looking For The Best Biotech Stocks To Watch? 3 To Consider Biotech stocks have been and still are on a tear in the stock market now. The industry as a whole is currently under the microscope of many investors. Obviously, this is due to the coronavirus pandemic that continues to plague the world. With over 95 million cases worldwide, investors would likely turn towards the top coronavirus stocks. However, it is often easy to overlook the fact that the top biotech stocks consist of a healthy mix...

Ford will shutter three plants and terminate about 5,000 jobs in Brazil by year-end as part of a global restructuring

Montrouge, France, January 7, 2021 DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process DBV Technologies S.A. (Euronext: DBV - ISIN: FR0010417345

DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process Montrouge, France, January 7, 2021 DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process DBV Technologies S.A. (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that it has determined that it now qualifies as a U.S. domestic issuer rather than a foreign...